Detection of six novel mutations in WASP gene in fifteen Iranian Wiskott-Aldrich patients

Iranian Journal of Allergy, Asthma and Immunology

Volumn 11, Issue 4, 2012, Pages 345-348

  Safaei, Sepideh ^a   Fazlollahi, Mohammad Reza ^a   Houshmand, Masoud ^b   Hamidieh, Amir Ali ^c   Bemanian, Mohammad Hassan ^d   Alavi, Samin ^e   Mousavi, Farideh ^f   Pourpak, Zahra ^a   Moin, Mostafa ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Institute of Genetic Engineering and Biotechnology   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Mutations; Thrombocytopenia; Wiskott Aldrich syndrome

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE; GENE DELETION; GENE INSERTION; GENE MUTATION; HUMAN; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS; STOP CODON; WASP GENE; WISKOTT ALDRICH SYNDROME;

CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; EXONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRAN; MALE; MUTATION; POLYMERASE CHAIN REACTION; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 84872434488     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Blundell MP, Bouma G, Calle Y, Jones GE, Kinnon C, Thrasher AJ. Improvement of migratory defects in a murine model of Wiskott-Aldrich syndrome gene therapy. Mol Ther 2008; 16(5):836-44. (Pubitemid 351587092)
2. Snapper SB, Meelu P, Nguyen D, Stockton BM, Bozza P, Alt FW, et al. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. J Leukoc Biol 2005; 77(6):993-8. (Pubitemid 40770852)
3. Morales-Tirado V, Sojka DK, Katzman SD, Lazarski CA, Finkelman FD, Urban JF, et al. Critical requirement for the Wiskott-Aldrich syndrome protein in Th2 effector function Blood; 2010; 115(17):3498-507.
4. Massaad MJ, Ramesh N, Le Bras S, Giliani S, Notarangelo LD, Al-Herz W, et al. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding. J Allergy Clin Immunol 2011; 127(4):998-1005.
5. Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, et al. Clinical course of patients with WASP gene mutations. Blood 2004; 103(2):456-64. (Pubitemid 38140073)
6. Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood 2004; 104:4010-9. (Pubitemid 39620151)
7. Jones LN, Lutskiy MI, Cooley J, Kenney DM, Rosen FS, Remold-O'Donnell EA. Novel Protocol to Identify Mutations in Patients with Wiskott-Aldrich Syndrome. Blood Cells Mol Dis 2002; 28, (3): 392-8.
8. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994; 78(4):635-44. (Pubitemid 24268586)
9. Finan PM, Soames CJ, Wilson L, Nelson DL, Stewart DM, Truong O, et al. Identification of regions of the Wiskott-Aldrich syndrome protein responsible for association with selected Src homology 3 domains. J Biol Chem 1996; 271(42):26291-5. (Pubitemid 26347479)
10. Thompson LJ, Lalloz MRA, Layton DM. Unique and Recurrent WAS Gene Mutations in Wiskott - Aldrich syndrome and X-Linked Thrombocytopenia. Blood Cells Mol Dis 1999; 25(3-4):218-26. (Pubitemid 29521423)
11. Symons M, Derry JM, Karlak B, Jiang S, Lemahieu V, Mccormick F, et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 1996; 84(5):723-34. (Pubitemid 26094202)
12. Burns S, Cory GO, Vainchenker W, Thrasher AJ. Mechanisms of WASP-mediated hematologic and immunologic disease. Blood 2004; 104(12):3454-62. (Pubitemid 39564413)
13. Sasahara Y, Rachid R, Byrne MJ, de la Fuente MA, Abraham RT, Ramesh N, et al. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol Cell 2002; 10(6):1269-81. (Pubitemid 36050870)
14. Luthi JN, Gandhi MJ, Drachman JG. X-linked thrombocytopenia caused by a mutation in the Wiskott-Aldrich syndrome (WAS) gene that disrupts interaction with the WAS protein (WASP) - interacting protein (WIP). Exp Hematol 2003; 31(2):150-8. (Pubitemid 36184640)
15. Konno A, Kirby M, Anderson SA, Schwartzberg PL, Candotti F. The expression of Wiskott-Aldrich syndrome protein (WASP) is dependent on WASP-interacting protein (WIP). Int Immunol 2007; 19(2):185-92. (Pubitemid 46179013)
16. Hwang DJ, Yang JW, Kim SY, Yi HK, Lee DY, Hwang PH. Diagnostic Approach of Wiskott - Aldrich syndrome. Korean J Pediatr 2004; 47(7):726-34.
17. Rong, S.B, Vihinen, M. Structural basis of Wiskott-Aldrich syndrome causing mutations in the WH1 domain. J Mol Med 2000; 78(9):530-7.